MIR4439

Across TCGA pan-cancer cohorts, MIR4439 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR4439 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR4439 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4439 expression acts as an unfavorable survival marker.

MESO, THCA, and LUSC are the cancer types where MIR4439 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	126	view →
THCA	DFS	Tertile	All	0.116	0.819	<.001	90	view →
LUSC	DFS	Tertile	All	0.375	0.664	.007	51	view →
OV	OS	Tertile	IV	0.262	0.766	.001	36	view →
COAD	OS	Tertile	III,IV	0.163	0.791	.004	36	view →
SKCM	DFS	Tertile	II,III,IV	0.357	0.577	.008	30	view →
BLCA	DFS	Tertile	All	0.203	0.522	.022	27	view →
THYM	DFS	Tertile	All	0.577	0.920	.016	18	view →
PRAD	OS	Tertile	All	0.265	0.884	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR4439–MESO (OS)

Open the MESO breakdown →